Stock listing
MNOV Stock Price, News, Filings & Events — Medicinova, Inc.
Selected listing: MNOV · BOATS · USD · US
This page tracks Medicinova, Inc.'s MNOV:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MNOV:BOATS. MNOV:BOATS is the stock-level entry point for investors researching Medicinova, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medicinova, Inc. (MNOV) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- MNOV:BOATS
- Asset type
- Stock
- Market cap
- $89.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Medicinova, Inc. MNOV:BOATS stock context
This page tracks Medicinova, Inc.'s MNOV:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MNOV:BOATS. MNOV:BOATS is the stock-level entry point for investors researching Medicinova, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medicinova, Inc. (MNOV) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Medicinova, Inc.
MediciNova to Participate in Two Investor Conferences in September
September 8, 2026
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS ...
July 15, 2026
MediciNova CEO Provides Shareholder Update
June 30, 2026
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor f...
June 8, 2026
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
May 26, 2026
Research Medicinova, Inc.
Medicinova, Inc. investor report
Review AI stock analysis and investor report context for MNOV:BOATS.
Medicinova, Inc. company profile
View the public company page for Medicinova, Inc. on 6ix.
Medicinova, Inc. news
Read company news and market updates connected to Medicinova, Inc..
Medicinova, Inc. investor events
Find investor webinars, events, and replay context for Medicinova, Inc..